Effect of oral immunotherapy with hypoallergenic formula for severe milk allergenic patients
Not Applicable
- Conditions
- severe milk allergy
- Registration Number
- JPRN-UMIN000013374
- Lead Sponsor
- Fujita Health University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Use of antihistamines within three days prior to double blind placebo controlled food challenge (DBPCFC) Uncontrolled bronchial asthma. judged inappropriate for this study by doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The improvement of tolerance to milk of children in each study group
- Secondary Outcome Measures
Name Time Method Milk specific-IgE, peripheral basophil activation against milk, milk specific-T cell activation